An observational study in Obstructive Sleep Apnoea Syndrome and Nasal Obstruction, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-03-13.
Sponsored by Norwegian University of Science and Technology · Observational
Recent clinical findings of research at Trondheim University Hospital suggest that surgical correction of the nose septum in addition to volume reduction of the nose cavity may be beneficial in patients who suffer from both nose obstruction and obstructive sleep apnea syndrome(data not yet published).
This study aims to compare nose obstruction prevalence in sleep apnea patients and the general population
1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.
This study's enrollment of 217 is above the median of 106 across 386 observational studies indexed under Apnea.
Browse Apnea studies →Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients: St Olavs Hospital, Trondheim, Norway Controls: Community sample, residents of Trøndelag, Norway
Exclusion Criteria:
100 patients suffering from obstructive sleep apnea syndrome
100 subjects matching cases to age, sex, and body weight
patient reported nasal obstruction
assessed by a 10-point visual analogue scale (VAS) and Sino Nasal Outcome Score(SNOT-20) questionnaire.
Time frame: 1 week
objective nasal obstruction
measured by acoustical rhinometry and Peak Nasal Inspiratory Flow (PNIF).
Time frame: 1 week
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Norwegian University of Science and Technology